抗体鸡尾酒疗法市场：按类型、适应症、分销管道和地区划分

预计到2026年，抗体鸡尾酒疗法市场规模将达22亿美元，到2033年将达到73亿美元。预计从2026年到2033年，该市场将以17.7%的复合年增长率成长。

抗体（又称免疫球蛋白）是人体免疫系统针对称为抗原的外来物质所产生的防御性蛋白质。抗原包括多种物质，如病原体、昆虫毒液、细菌和病毒。抗体鸡尾酒疗法基本上是两种不同抗体的组合。采用鸡尾酒疗法组合两种抗体的目的是为了最大限度地减少病毒变异导致的免疫逃脱。

市场动态

预计在预测期内，市场主要企业越来越多地采用非内生性成长策略，例如建立合作伙伴关係和签署协议，将推动市场成长。例如，2021年5月，跨国医疗保健公司罗氏（F. Hoffmann-La Roche）与跨国製药公司西普拉（Cipla）达成策略合作。根据合作协议，罗氏将把其抗体鸡尾酒疗法（卡西利单抗和伊维单抗）进口到印度，并透过西普拉的分销网络在印度进行销售和分销。

此外，2020年8月，跨国医疗保健公司罗氏（F. Hoffmann-La Roche）和生物技术公司再生元製药（Regeneron Pharmaceuticals）宣布达成协议，共同开发、生产和供应再生元临床实验的抗病毒抗体鸡尾酒疗法REGN-COV2，以服务全球患者。此次合作预计将使REGN-COV2的供应量至少提升至目前产能的3.5倍，并具有进一步扩大的潜力。根据协议，再生元将负责REGN-COV2在美国的经销，而罗氏将负责美国以外地区的经销。

本报告的主要特点

• 本报告指出了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
• 此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
• 本文根据以下参数，介绍了全球抗体鸡尾酒疗法市场主要企业的概况：公司概况、产品系列、主要亮点、财务表现和策略。
• 本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
• 《全球抗体鸡尾酒市场》报告面向该行业的众多相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过分析全球抗体鸡尾酒疗法市场中使用的各种策略矩阵来促进决策。

目录

第一章：分析目标与假设

• 分析目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章：市场动态、监管与趋势分析

• 市场动态
  • 促进因素
  • 阻碍因素
  • 市场机会
• 影响分析
• 市场趋势
• 管道分析
• 监管趋势
• 救赎方案
• 产品发布
• PEST分析

第四章：全球抗体鸡尾酒疗法市场：按类型划分（2026-2033 年）

• 概述
• 单价抗体
• 多价抗体

第五章：全球抗体鸡尾酒疗法市场：依适应症划分（2026-2033 年）

• 概述
• COVID-19
• 癌症
• HIV
• 其他的

第六章：全球抗体鸡尾酒疗法市场：按分销管道划分（2026-2033 年）

• 概述
• 医院药房
• 零售药房
• 网路药房

第七章 全球抗体鸡尾酒疗法市场：按地区划分（2026-2033 年）

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
• 中东
  • 波湾合作理事会（GCC）国家
  • 以色列
  • 其他中东国家
• 非洲
  • 北非
  • 中非
  • 南非

第八章 竞争情势

• Cipla Inc.
• F. Hoffmann-La Roche Ltd
• Regeneron Pharmaceuticals Inc.
• Zydus Cadila
• AstraZeneca
• Aridis Pharmaceuticals Inc.
• AstraZene Immunome Inc.
• Celltrion Healthcare Co., Ltd.
• Eli Lilly and Company

第九章

• 分析方法
• 关于 Coherent Market Insights

Antibody Cocktails Market is estimated to be valued at USD 2.2 Bn in 2026 and is expected to reach USD 7.3 Bn by 2033, growing at a compound annual growth rate (CAGR) of 17.7% from 2026 to 2033.

An antibody, also called immunoglobulin, is a protective protein produced by the immune system of the body in response to the presence of a foreign substance, called an antigen. Antigens are a wide range of substances that include disease-causing organisms and toxic materials such as insect venom, bacteria, or viruses. An antibody cocktail is basically a combination or cocktail of two different antibodies. The rationale behind combining two antibodies in a cocktail approach is to minimize mutational viral escape.

Market Dynamics

The increasing adoption of inorganic strategies such as partnerships and agreements by key players in the market is expected to drive the market growth during the forecast period. For instance, in May 2021, F. Hoffmann-La Roche Ltd., a multinational healthcare company, and Cipla Inc., a multinational pharmaceutical company, entered into a strategic partnership by which F. Hoffmann-La Roche Ltd., will import its antibody cocktail (Casirivimab and Imdevimab) medication into India, where it will then be marketed and distributed by the Cipla's distribution network.

Moreover, in August 2020, F. Hoffmann-La Roche Ltd., a multinational healthcare company, and Regeneron Pharmaceuticals Inc., a biotechnology company, announced that they had agreed to develop, manufacture, and distribute REGN-COV2, Regeneron's investigational antiviral antibody cocktail, to people around the globe. This collaboration is expected to increase the supply of REGN-COV2 by at least three and a half times the current capacity, with the potential for even further expansion. As a part of this agreement, Regeneron will be responsible for distributing REGN-COV2 in the U.S. and Roche will distribute it outside the U.S., as a part of this agreement.

Key features of the study

• This report provides an in-depth analysis of the global antibody cocktails market, and provides market size (US$ million) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global antibody cocktails market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Cipla Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Zydus Cadila, AstraZeneca, Aridis Pharmaceuticals Inc., Immunome Inc., Celltrion Healthcare Co., Ltd., and Eli Lilly and Company
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global antibody cocktails market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibody cocktails market

Market Segmentation

• By Type
  • Monovalent Antibody
  • Polyvalent Antibody
• By Indication
  • COVID-19
  • Cancer
  • HIV
  • Others
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Regional Insights
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Cipla Inc.
  • Hoffmann-La Roche Ltd
  • Regeneron Pharmaceuticals Inc.
  • Zydus Cadila
  • AstraZeneca
  • Aridis Pharmaceuticals Inc.
  • Immunome Inc.
  • Celltrion Healthcare Co.,Ltd.
  • Eli Lilly and Company.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Indication
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Pipeline Analysis
• Regulatory Scenario
• Reimbursement Scenario
• Product Launches
• PEST Analysis

4. Global Antibody Cocktails Market, By Type, 2026 - 2033, (USD Bn)

• Overview
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021-2033
  • Segment Trends
• Monovalent antibody
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Polyvalent antibody
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Antibody Cocktails Market, By Indication, 2026 - 2033, (USD Bn)

• Overview
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021-2033
  • Segment Trends
• COVID-19
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• HIV
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Antibody Cocktails Market, By Distribution Channel, 2026 - 2033, (USD Bn)

• Overview
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021-2033
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Antibody Cocktails Market, By Region, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
    • UK
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021-2033, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Cipla Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• F. Hoffmann-La Roche Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Regeneron Pharmaceuticals Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Zydus Cadila
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• AstraZeneca
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Aridis Pharmaceuticals Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• AstraZene Immunome Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Celltrion Healthcare Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Eli Lilly and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Section

• Research Methodology
• About Us